Literature DB >> 21262940

Preventing congenital varicella syndrome with immunization.

Andreas Sauerbrei1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21262940      PMCID： PMC3042473          DOI： 10.1503/cmaj.110055

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin.

Authors:  Arlan Cohen; Panagis Moschopoulos; Panagis Maschopoulos; Richard E Stiehm; Gideon Koren
Journal:  CMAJ       Date:  2011-01-24       Impact factor: 8.262

Review 2.  The congenital varicella syndrome.

Authors:  A Sauerbrei; P Wutzler
Journal:  J Perinatol       Date:  2000-12       Impact factor: 2.521

Review 3.  Chickenpox in pregnancy: revisited.

Authors:  Michael Paul Tan; Gideon Koren
Journal:  Reprod Toxicol       Date:  2005-06-23       Impact factor: 3.143

4.  Serum concentrations, efficacy, and safety of a new, intravenously administered varicella zoster immune globulin in pregnant women.

Authors:  Gideon Koren; Deborah Money; Marc Boucher; Fred Aoki; Martin Petric; Gilda Innocencion; Michael Wolosk; Valencia Remple; Francine Pelland; Ruth Geist; Tommy Ho; Benny Bar-Oz; Ronen Loebstein
Journal:  J Clin Pharmacol       Date:  2002-03       Impact factor: 3.126

5.  Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases.

Authors:  G Enders; E Miller; J Cradock-Watson; I Bolley; M Ridehalgh
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

6.  Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry.

Authors:  Eileen Wilson; Mary Ann Goss; Mona Marin; Kristine E Shields; Jane F Seward; Sonja A Rasmussen; Robert G Sharrar
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

7.  Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella.

Authors:  J A Zaia; M J Levin; S R Preblud; J Leszczynski; G G Wright; R J Ellis; A C Curtis; M A Valerio; J LeGore
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

8.  Outcome after maternal varicella infection in the first 20 weeks of pregnancy.

Authors:  A L Pastuszak; M Levy; B Schick; C Zuber; M Feldkamp; J Gladstone; F Bar-Levy; E Jackson; A Donnenfeld; W Meschino
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245
  8 in total
  2 in total

Review 1.  Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections.

Authors:  A Sauerbrei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

Review 2.  [Herpes zoster and postherpetic neuralgia].

Authors:  U Wollina; J Machetanz
Journal:  Hautarzt       Date:  2016-08       Impact factor: 0.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.